Impact of Adalimumab (HUMIRA®) on Work Productivity in Patients With Psoriatic Arthritis: Results From ACCLAIM

被引：0
|
作者：
Gladman, D. D. [1 ]
Psaradellis, F. [2 ]
Martel, M. J. [3 ]
Illouz, O. [3 ]
Guerette, B. [4 ]
Sampalis, J. S. [2 ,5 ,6 ,7 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] JSS Med Res, Montreal, PQ, Canada
[3] Abbott Labs, St Laurent, PQ, Canada
[4] Abbott Labs, Rungis, France
[5] McGill Univ, Montreal, PQ H3A 2T5, Canada
[6] Univ Montreal, Montreal, PQ H3C 3J7, Canada
[7] Univ Laval, Quebec City, PQ G1K 7P4, Canada
来源：
JOURNAL OF RHEUMATOLOGY | 2009年 / 36卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
111
引用
收藏
页码：2595 / 2596
页数：2
相关论文
共 50 条
  • [1] Impact of Adalimumab (HUMIRA®) on Work Productivity in Patients with Psoriatic Arthritis: Results from ACCLAIM
    Gladman, Dafna D.
    Psaradellis, Fotoula
    Martel, Marie-Josee
    Illouz, Olivier
    Guerette, Benoit
    Sampalis, John S.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S148 - S149
  • [2] Effectiveness of adalimumab (Humira) in clinical practice: Results from the ACCLAIM study in patients with psoriatic arthritis
    Gladman, D. D.
    Wong, R. L.
    Guerette, B.
    [J]. JOURNAL OF RHEUMATOLOGY, 2008, 35 (06) : 1185 - 1186
  • [3] Reliability and validity of the work limitations questionnaire (WLQ) and impact of adalimumab (HUMIRA®) on presenteeisna for patients with psoriatic arthritis (PsA):: Results of ACCLAIM.
    Gladman, Daftia D.
    Sampalis, John S.
    Martel, M. J.
    Gooch, Katherine L.
    Wong, Robert
    Guerette, Benoit
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S202 - S202
  • [4] Impact of Adalimumab on Presenteeism for Patients with Psoriatic Arthritis and Reliability and Validity of the Work Limitations Questionnaire: Results of ACCLAIM
    Gladman, D. D.
    Sampalis, J. S.
    Martel, M. J.
    Gooch, K. L.
    Wong, R. L.
    Guerette, B.
    [J]. JOURNAL OF RHEUMATOLOGY, 2009, 36 (11) : 2595 - 2595
  • [5] Reliability and Validity of the Work Limitations Questionnaire in Patients with Psoriatic Arthritis: Results from ACCLAIM
    Sampalis, John S.
    Gladman, Dafna D.
    Martel, Marie-Josee
    Gooch, Kathy L.
    Wong, Robert L.
    Guerette, Benoit
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S260 - S260
  • [6] Clinical remission in patients with psoriatic arthritis (PsA) treated with adalimumab (humira®). results of the stereo trial
    Van den Bosch, F.
    Manger, B.
    Goupille, P.
    McHugh, N.
    Kron, M.
    Kary, S.
    Kupper, H.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (04) : 743 - 743
  • [7] Improvement in health utility in patients with psoriatic arthritis treated with adalimumab (HUMIRA®)
    Anis, AH
    Guh, D
    Melilli, LE
    [J]. VALUE IN HEALTH, 2005, 8 (06) : A27 - A27
  • [8] Improvement in health utility in patients with psoriatic arthritis treated with adalimumab (HUMIRA®)
    Guh, D
    Bansback, NJ
    Nosyk, B
    Melilli, LE
    Anis, A
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 401 - 401
  • [9] Adalimumab (HUMIRA®) improves work productivity in patients with Ankylosing spondylitis:: results from the RHAPS06Y trial
    Rudwaleit, Martin
    Boki, Kyriaki
    Gooch, Katherine L.
    Wong, Robert
    Chen, Naijun
    Kupper, Hartmut
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S210 - S210
  • [10] Real-World Postmarketing Study of the Impact of Adalimumab Treatment on Work Productivity and Activity Impairment in Patients with Psoriatic Arthritis
    Nakagawa, Hidemi
    Tanaka, Yoshiya
    Sano, Shigetoshi
    Kameda, Hideto
    Taniguchi, Atsuo
    Kashiwagi, Tomoko
    Kawaberi, Takeshi
    Kimura, Junko
    Morita, Akimichi
    [J]. ADVANCES IN THERAPY, 2019, 36 (03) : 691 - 707
12345